Zentalis Pharmaceuticals, Inc. (ZNTL)
 NASDAQ: ZNTL · Real-Time Price · USD
 1.485
 -0.045 (-2.94%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Zentalis Pharmaceuticals Employees
Zentalis Pharmaceuticals had 166 employees as of December 31, 2024. The number of employees decreased by 2 or -1.19% compared to the previous year.
Employees 
 166
Change (1Y) 
 -2
Growth (1Y) 
 -1.19%
Revenue / Employee 
 $161,837
Profits / Employee 
 -$980,620
Market Cap 
107.12M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 166 | -2 | -1.19% | 
| Dec 31, 2023 | 168 | 12 | 7.69% | 
| Dec 31, 2022 | 156 | -21 | -11.86% | 
| Dec 31, 2021 | 177 | 53 | 42.74% | 
| Dec 31, 2020 | 124 | 62 | 100.00% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
ZNTL News
- 17 days ago - Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 4 weeks ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Zentalis Pharmaceuticals, Inc. (ZNTL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary - GlobeNewsWire
- 3 months ago - Zentalis Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Progress - GlobeNewsWire
- 4 months ago - Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 months ago - Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress - GlobeNewsWire